Bupivacaine with Epinephrine in Adult Regional Anesthesia
Adding epinephrine to bupivacaine increases the maximum safe dose from 175 mg to 225 mg (approximately 2.5 mg/kg to 3 mg/kg) and prolongs the duration of anesthesia by 30-60 minutes, making it the preferred approach for most regional blocks unless contraindicated. 1
Maximum Dose Limits
Without Epinephrine
- Maximum single dose: 175 mg (approximately 2.5 mg/kg) 1
- Maximum daily dose: 400 mg 1
- Doses may be repeated every 3 hours 1
With Epinephrine (1:200,000)
- Maximum single dose: 225 mg (approximately 3 mg/kg) 1, 2
- Maximum daily dose: 400 mg 1
- Epinephrine concentration: 5 mcg/mL (1:200,000) 1
- Duration of action: 180-600 minutes 2
When to Add Epinephrine
Add epinephrine in these situations:
- Large-volume blocks requiring higher doses of local anesthetic 3
- When prolonged duration of anesthesia is desired (adds 30-60 minutes) 4
- Peripheral nerve blocks where systemic absorption is a concern 5
- Epidural anesthesia when extended surgical time is anticipated 6
The addition of epinephrine reduces systemic absorption and peak plasma concentrations, decreasing toxicity risk 5, 7. For intrathecal use, epinephrine 100-200 mcg prolongs sensory blockade by 30-60 minutes and motor blockade similarly 6, 4.
Absolute Contraindications
Do not use epinephrine-containing solutions in:
- End-artery territories: digits, penis, nose, external ear 1
- Intravenous regional anesthesia (Bier blocks) 1
- Obstetrical paracervical blocks 1
- Patients with severe hypertensive vascular disease 1
Relative Contraindications and Cautions
Exercise caution with epinephrine in:
- Patients on beta-blockers (may not show heart rate increase with intravascular injection; monitor blood pressure instead) 1
- During or after potent inhalation anesthetics (risk of cardiac arrhythmias) 1
- Compromised blood supply areas 1
- Patients with significant cardiovascular disease 1
Concentration-Specific Guidance
0.25% Bupivacaine
- Produces incomplete motor block 1
- Use for procedures not requiring muscle relaxation 1
- Slower onset than higher concentrations 1
0.5% Bupivacaine
- Provides adequate motor blockade for most procedures 1
- Standard concentration for peripheral nerve blocks 8
- With epinephrine: recommended for dental blocks (1.8 mL = 9 mg per site, max 90 mg total) 1
0.75% Bupivacaine
- Produces complete motor block 1
- Contraindicated for obstetrical anesthesia 1
- Reserved for procedures requiring complete muscle relaxation 1
Epidural-Specific Dosing
Administer in incremental doses of 3-5 mL with sufficient time between doses to detect intravascular or intrathecal injection 1
- Test dose: 15 mg bupivacaine + 15 mcg epinephrine in 3 mL 1
- Monitor heart rate for 45 seconds after test dose (increase >20 bpm for >15 seconds indicates intravascular injection) 1
- For obstetrics: use only 0.25% or 0.5% concentrations, not exceeding 50-100 mg per dosing interval 1
Age-Related Dose Adjustments
Reduce doses by 30% in:
Pediatric maximum doses (with epinephrine):
Common Pitfalls to Avoid
- Rapid injection of large volumes: Always use fractional doses with frequent aspiration 1
- Ignoring test dose results: Even negative aspiration doesn't exclude intravascular placement 1
- Inadequate monitoring: Watch for early CNS toxicity signs (restlessness, metallic taste, tinnitus, perioral numbness) 1
- Exceeding daily maximum: 400 mg/24 hours regardless of epinephrine use 1
- Using preserved solutions for neuraxial blocks: Only preservative-free formulations for epidural/spinal 1
Disease-Specific Modifications
Hepatic disease: Reduce doses for repeat/continuous administration due to decreased clearance 1, 3
Cardiac disease: Use cautiously; patients may be less able to compensate for AV conduction prolongation 1
Renal disease: Reduce doses for repeated administration 3
The evidence consistently demonstrates that epinephrine addition is both safe and beneficial for most regional anesthesia applications, with the primary benefit being increased maximum safe dose and modestly prolonged duration 4.